Home / Health / Experimental Gum Slashes HPV Levels
Experimental Gum Slashes HPV Levels
12 Nov
Summary
- Experimental gum reduced HPV by 93% in lab saliva samples.
- Gum contains compounds derived from bioengineered beans.
- Human trials are needed to confirm safety and efficacy.
Scientists at the University of Pennsylvania have created an experimental chewing gum that demonstrated a significant reduction in cancer-linked human papillomavirus (HPV) levels. In laboratory tests using saliva samples from patients with head and neck cancer, HPV was reduced by up to 93 percent.
The innovative gum utilizes compounds extracted from bioengineered beans. Researchers are hopeful this delivery method could eventually aid in controlling microbes linked to head and neck cancers, potentially complementing current medical treatments.
Further research, including human clinical trials, is essential. These trials will establish the gum's safety, optimal dosage, and verify if the promising laboratory findings translate to actual health benefits in people.
Currently, this experimental product is not a substitute for established preventative measures like HPV vaccination or regular medical check-ups. Its development represents a potential future tool against cancer-associated infections, pending conclusive human study results.
